Synutra Announces Pricing of Follow-On Public Offering

Jun 25, 2010, 09:11 ET from Synutra International, Inc.

QINGDAO, China and Rockville, Md., June 25 /PRNewswire-Asia/ -- Synutra International, Inc. (Nasdaq: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced the pricing of a public offering of 3.3 million common shares at $19.00 per share.

The underwriters have been granted a 30-day option to purchase up to 495,000 additional shares from the Company to cover over-allotments, if any. The offering is expected to close on or about June 30, 2010, subject to customary closing conditions.

The net proceeds to the Company from this offering will be approximately $59.565 million, not including the over-allotment option, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Company intends to use up to $35 million from the net proceeds to repay debt outstanding under its credit agreement with RBS, and the remainder for general corporate purposes.

Oppenheimer & Co. Inc. and ROTH Capital Partners, LLC are acting as joint bookrunners for the offering.

The offering was made pursuant to the Company's registration statement, which was declared effective on May 12, 2010 by the U.S. Securities and Exchange Commission.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. The offering may only be made by means of a prospectus. A preliminary prospectus supplement relating to the offering has been filed with the U.S. Securities and Exchange Commission.

A copy of the prospectus and the final prospectus supplement relating to the offering may be obtained when available by visiting EDGAR on the SEC's Web site at http://www.sec.gov and from Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 300 Madison Avenue, 4th Floor, New York, NY 10017, by telephone at (212) 667-8563, by facsimile at (212) 667-6141 or via e-mail at EquityProspectus@opco.com.

About Synutra International, Inc.

Synutra International Inc. (Nasdaq: SYUT) is a leading infant formula company in China. It principally produces, markets and sells its products under the "Shengyuan" or "Synutra" name, together with other complementary brands. It focuses on selling premium infant formula products, which are supplemented by more affordable infant formulas targeting the mass market as well as other nutritional products and ingredients. It sells its products through an extensive nationwide sales and distribution network covering 30 provinces and provincial-level municipalities in China. As of March 31, 2010, this network comprised over 540 independent distributors and over 1,000 independent sub-distributors who sell Synutra products in over 71,000 retail outlets.

    For further information, please contact:

     Synutra International, Inc.
     Investor Relations Department
     Phone: +1-301-840-3888

SOURCE Synutra International, Inc.